0000950170-23-056496.txt : 20231030 0000950170-23-056496.hdr.sgml : 20231030 20231030194244 ACCESSION NUMBER: 0000950170-23-056496 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231026 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cashman Neil CENTRAL INDEX KEY: 0001927064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41429 FILM NUMBER: 231361953 MAIL ADDRESS: STREET 1: C/O PROMIS NEUROSCIENCES INC. STREET 2: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 4 1 ownership.xml 4 X0508 4 2023-10-26 0001374339 ProMIS Neurosciences Inc. PMN 0001927064 Cashman Neil C/O PROMIS NEUROSCIENCES INC.,1920 YONGE STREET, SUITE 200 TORONTO A6 M4S 3E2 ONTARIO, CANADA true true false false Chief Scientific Officer false Option (right to buy) 1.87 2023-10-26 4 A false 12500 0 A 2033-10-26 Common Shares 12500 12500 D 25% of the shares subject to this option shall vest on October 26, 2024, and the balance shall vest ratably over 36 months. /s/ Max A. Milbury, Attorney-in-Fact for Neil Cashman 2023-10-30